Standout Papers

MicroRNA function in cancer: oncogene or a tumor suppressor? 2009 2026 2014 2020 558
  1. MicroRNA function in cancer: oncogene or a tumor suppressor? (2009)
    Sylvia Shenouda, Suresh K. Alahari Cancer and Metastasis Reviews
  2. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study (2012)
    John B. Buse, Michael A. Nauck et al. The Lancet

Immediate Impact

6 by Nobel laureates 5 from Science/Nature 93 standout
Sub-graph 1 of 21

Citing Papers

GLP-1-based therapies for diabetes, obesity and beyond
2025 Standout
Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
10 intermediate papers

Works of Sylvia Shenouda being referenced

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
2012 Standout

Author Peers

Author Last Decade Papers Cites
Sylvia Shenouda 902 611 75 478 16 1.5k
Daisuke Ogawa 778 786 63 206 49 2.2k
Silvia Pinach 607 535 45 188 43 1.9k
Zouher Majd 855 248 28 273 24 1.4k
Folke Schmidt 606 500 49 282 18 1.8k
Aldons J. Lusis 553 451 72 99 17 1.8k
Qing Lu 704 495 117 143 47 1.8k
Glenna L. Fry 613 390 47 324 34 1.9k
Réjane Paumelle 1009 316 51 213 31 1.9k
Robyn Cunard 948 632 37 117 32 2.1k
Mario N. Piccinni 560 825 35 138 31 1.3k

All Works

Loading papers...

Rankless by CCL
2026